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Abstract
Brain death is a highly debated and controversial topic spanning across several bodies of
knowledge. Controversies of brain death include, but are not limited to, lack of consensus, falsepositive diagnoses, residual function, public perception, and rights. Though brain death is often
sensationalized by the media, distrust by the general population is warranted. The lack of
consensus amongst professionals regarding brain death suggest that the American Academy of
Neurology’s criterion must be revised. At the minimum, revising of the AAN criterion should
focus on evolving ancillary testing, and establishing a minimum observation time before
declaring death. Upon further clarification of discrepancies, trust will be restored in the medical
community regarding end of life decisions.
Keywords: brain death, history, criteria, diagnosis, false-positives, public perception,
rights, organ donation, controversies, ancillary testing
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The History of Brain Death
For up until the middle of the 20th century, death was defined by the irreversible
cessation of circulation and respiration (De Georgia, 2014, p. 673). However, the emergence of
clinical technology would establish a new understanding of the end of life--brain death (BD).
The ideology surrounding the inception of the term “brain death” can be traced back as far as
300 B.C., beginning with a reflection of the connection of the soul, or mind, to the nervous
system. One of the first descriptions of this relationship is linked to Herophilus of Chalcedon
(Wijdicks, 2017, p. 1). At around 300 B.C., his anatomical observations were the first to describe
nerves, and he hypothesized their ability to induce sensation or manipulate movement (Bay &
Bay, 2010, p. 281). Galen, around 160 A.D., had also inferred the brain’s connection to the mind,
delineating the cranial nerves, and observing deficits in perception as a result of brain injury
(Wijdicks, 2017, p. 1). Despite such early speculations, the movement towards a new definition
was not incepted until the middle of the 20th century.
The introduction of the mechanical ventilator served as the dawn towards describing BD
with the emergence of the persisting, irreversible comatose patient (Wijidicks, 2017, p. 2). This
state of coma consisted of lack of brainstem function, excessive urine production, decrease in
vascular size, absence of electroencephalographic (EEG) activity, and profound neural
destruction uncovered during autopsy (Wijidicks, 2017, p. 2). In 1954, Robert Schwab, upon
analysis of a comatose patient suffering from massive brain damage, became the first to describe
a death despite the presence of active circulation. Patients were described as only being
temporarily maintained, as they would inevitably die from cardiac arrest. A similar conclusion
was also drawn out by French neurologists Wertheimer, Jouvet, and Descotes in their 1959
report Diagnosis of death of the nervous system in comas with respiratory arrest treated by
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artificial respiration (Wijidicks, 2017, p. 2). The absence of EEG activity, brain stem reflexes,
and respiration were consistent finding, thus formulating the term “death of the nervous system”.
However, another group of French neurologists, Mollaret and Goulon, were unsure of referring
to this condition as a death equivalent. Due to the high degree of uncertainty regarding whether
such criteria could establish a new definition of death, they preferred the term “beyond coma”
(De Georgia, 2014, p. 673). Regardless, Schwab disagreed with the notion, believing that EEG
technology and standardization of the appropriate criteria could provide assurance of the new
death equivalent (De Georgia, 2014, p. 673-674).
In 1963, Schwab introduced the criteria triad for BD determination. The criteria included:
unresponsive, dilated pupils with a lack of evocable reflexes, a flat EEG, and absence of
spontaneous respiration (apnea). Schwab stated that patients who met the three criteria, despite
functioning circulation, could be declared dead. Such criteria were based on his findings amongst
90 patients, whom all had profound neural necrosis at autopsy (De Georgia, 2014, p. 674). To
finalize and formally establish the new definition of death, an Ad Hoc Committee at Harvard
University was formed. In 1968, based on Schwab’s triad, the committee had formulated four
criteria: unresponsiveness to stimuli, lack of movement and respiration, lack of reflexes, and a
flat EEG. Though a flat EEG was determined to be a component in determining BD, as it would
reflect the underlying brain necrosis found at autopsy, many argued against it in favor of the
brain stem’s role in consciousness (De Georgia, 2014, p. 675). The Ad Hoc committee,
nonetheless, struggled with equating BD to death. Initially, they stated that the BD patient would
be “essentially dead”, as the condition would eventually lead to death via cardiac arrest (De
Georgia, 2014, p. 675). Schwab, despite developing the triad of BD criterion, was also reluctant.
He had begun to align more with Mollaret and Goulon, believing that the irreversible coma was
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not equal to death, only representing a prognosis of it. In the end, the Ad Hoc committee decided
to align with a more cautionary position, and developed the “A Definition of Irreversible Coma”
to serve as a practical, and ethical guidance for physicians (De Georgia, 2014, p. 675).
Despite the Ad Hoc committee’s cautionary position, the definition of the irreversible
coma as BD was met with skepticism and concern. Many believed the article had a utilitarian
tone, with motives to establish BD as a means of increasing the numbers of hospital beds, or with
benefitting organ transplantation (De Georgia, 2014, p. 675). Tension surrounding organ
donation and BD was plausible, as transplantation efforts were occurring concurrently
(Machado, et al., 2007). However, separation was difficult, if not impossible. Even Joseph
Murray, a pioneer of transplantation and member of the Ad Hoc committee, noted that BD was
not created to benefit organ donation, but at the same time potential organs were being wasted
(De Georgia, 2014, p. 675). Nonetheless, in the 1970s, BD started to become recognized as new
death equivalent, though varying in criterion across the United States. Some states had
eliminated the need for an isoelectric EEG by reaffirming importance of the brain stem instead.
This notion was also established in much of the UK (De Georgia, 2014, p. 676).
The legal recognition of BD as equivalent to death across the states created the need for
uniformity in the country. The President’s Commission was convened in 1979 to establish a
uniform, and concise definition of death to include BD. The Commission was heavily inspired by
James Bernat’s On the Definition of Death and Criterion of Death (De Georgia, 2014, p. 676).
Bernat’s ideology of death was defined as “the permanent cessation of functioning of the
organism as a whole” (Bernat, et al., 1981). Coinciding this, Bernat had developed the “whole
brain criterion”, given that function of the brain, including the brainstem, was critical for the
survival of the organism (Bernat, et al., 1981). Relating to Bernat’s whole brain criterion, the
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Commission established the brain as the master regulator of all bodily function, whose absence
would inevitably result in body’s inability to maintain itself, as characteristic of death. This
statement by the Commission would result in the Uniform Declaration of Death Act (UDDA) of
1981, formally finalizing BD as a new death equivalent (De Georgia, 2014, p. 676).

Determining Brain Death
The Current Definition and Criteria
The current definition of BD, as established in the UDDA in 1981 is as follows:
“irreversible cessation of all functions of the entire brain, including the brain stem” (Sade, 2011,
p. 1-2). By including BD into the UDDA, the term became equated to the traditional view of
cardiac death, which would suggest the brain to promote critical, integrative functions of the
entire body (De Georgia, 2014). In the Evidence-based guideline update: Determining brain
death in adults Report of the Quality Standards Subcommittee of the American Academy of
Neurology, BD is currently characterized by irreversible coma, lack of brain stem reflexes, and
apnea (Wijdicks, et al., 2010, p. 1914).
Despite advancements in clinical technology, there have been very little changes in
criteria for BD as established by the American Academy of Neurology (AAN) in 1995. There is
currently no standardized, minimal neurological observation period required to ensure permanent
loss of function. In addition, ancillary tests like magnetic resonance imaging (MRI), magnetic
resonance angiography (MRA), CT angiography (CTA), and somatosensory evoked potentials
(SSEPs), have not been proven to be statistically significant in the diagnosis of BD (Wijdicks, et
al., 2010, p. 1913-1914). As such, the AAN follows a “practical, non-evidence” based method in
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establishing a diagnosis. Determination follows four steps: clinical evaluation, neurological
assessment, ancillary tests, and documentation of the BD (Wijdicks, et al., 2010, p. 1914).
I. Clinical Evaluation
Clinical evaluation begins with establishment and determination of the coma. Following
coma analysis, any drugs remaining in the patient must be metabolized, including depressants of
the nervous system and neuromuscular blockers. Any abnormal presence of electrolytes or
hormonal imbalance should also be ruled out. A normal, core body temperature is then
established usually with a warming blanket. Core temperature should be maintained above, or
near, 36°C (Wijdicks, et al., 2010, p. 1914). Maintaining a normal, core body temperature
prevents delayed rising of PaCO2, ensuring optimal conditions for the eventual apnea test. Upon
reaching the optimal body temperature, normal systolic blood pressure above, or equal to 100
mm Hg is achieved (Wijdicks, et al., 2010, p. 1915).
II. Neurological Assessment
Optimal, bodily conditions permit the neurologic examination portion of the clinical
evaluation. Currently, only one neurological examination is needed (and is deemed sufficient in
the majority of the United States). There are some states, however, that require at least two
neurological evaluations. Several hours must be allowed to pass before the neurological
evaluation. All physicians, regardless of specialty and expertise, are permitted to establish BD;
however, they must be competent, and versed in the corresponding criteria before diagnosis.
During the neurological assessment, the comatose patient must lack responsiveness to noxious
stimuli, including demonstrating a total lack of eye movement and motor reflexes (other than
those mediated by the spine). The lack of brainstem reflexes is especially critical, and assessed
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via the absence of pupillary, ocular, oculovestibular, corneal, facial muscle, pharyngeal, and
tracheal reflexes (Wijdicks, et al., 2010, p. 1915).
The pupillary response is assessed by shining a bright light into the eyes, and determining
dilation of the pupils. Constriction of pupils in response to light is indicative of brain stem
function, or the presence of drugs. The presence of ocular reflexes, under the pretense of an
intact cervical spine, are assessed by rotating the head. Eye movement should not occur in
relation to head rotation. Oculovestibular reflexes are assessed by irrigating 50 mL of ice water
into the ear canal. Ocular movements are observed for one minute, and should not be seen on
both sides. The corneal reflex is determined by swabbing the eye with a piece of cotton, tissue
paper, or by squirting with water; no eyelid movement should occur. To assess facial muscle
reflexes, deep pressure is applied to the condyles of the temporomandibular joint and the
supraorbital ridge. Facial muscle movement, in any capacity, should not be observed. The
responses of the pharynx and trachea, the final set of brainstem reflexes, are conducted
simultaneously. A suction device, or tongue blade, stimulates the posterior of the pharynx. The
absence of a gag reflex and cough determines the lack of the pharyngeal and tracheal response
respectively (Wijdicks, et al., 2010, p. 1915). The absence of all brainstem reflexes permits the
final portion of the neurological assessment: the apnea test.
The apnea test is the final component in determining total loss of brainstem function, that
is, to prove the absence of respiration without artificial support (Scott, et al., 2013, p. 533).
Before conducting the apnea test, the patient must exhibit sufficient blood concentration, optimal
PaCO2 levels of 35-45 mm Hg, lack of hypoxia, absence of CO2 retention, normal blood pressure
and core body temperature (Wijdicks, et al., 2010, p. 1915). Upon determining optimal bodily
conditions, vasopressors are set to the systolic blood pressure (100 mm Hg). Oxygenation of
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100% O2 with PaO2 above 200 mm Hg is maintained for 10 minutes, after which ventilation
frequency is diminished to 10 breaths per minute. Baseline blood gas is recorded if the O2 is
above 95%. The ventilator is subsequently disconnected, upon which signs of respiration are
observed. Notable signs of respiration include abdominal risings, or gasps of air. The arterial
blood gas is then measured after approximately 8-10 minutes. If pCO2 is ≥ 60 mm Hg (or 20 mm
Hg higher than the initial baseline recording), and no indications of respiration are observed, the
apnea test confirms the diagnosis of BD. The apnea test is considered negative, or inconclusive,
if any of the following occur: systolic blood pressure decreases to below 90 mm Hg, oxygen
saturation is above 85% for more than 30 seconds, and spontaneous respiration (Wijdicks, et al.,
2010, p. 1915-1916). If proven inconclusive and the patient has a stable blood circulation, the
test can be repeated. Otherwise, ancillary tests are generally used to confirm the BD diagnosis
(Wijdicks, et al., 2010, p. 1916).
III. Ancillary Tests
Ancillary tests are generally used, at the discretion of the physician, when uncertainty
exists regarding the state of BD. The AAN states that use of such tests are unneeded when
diagnosing adult patients, and cannot substitute the neurological assessment. In the event
ancillary tests are used, the AAN recommends an expert opinion. Ancillary tests of choice
include: EEG, cerebral angiography, MRI, MRA, nuclear scans, transcranial doppler (TCD), and
CTA. MRI, MRA, and CTA are not found to be statistically significant in BD diagnosis; utmost
caution must be used in the event of false-positives (Wijdicks, et al., 2010, p. 1916).
IV. Documentation of Brain Death
Upon confirmation, the time of death is recorded. The time of death is established the
moment arterial PCO2 is at the appropriate level with a positive apnea test. The time of death is
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otherwise noted upon confirmation with an ancillary examination. Retrieval of organs occurs
promptly after declaration of death, provided that the deceased, or respective representatives,
have given approval (Wijdicks, et al., 2010, p. 1916-1917).

Controversies of Brain Death Diagnosis
Lack of Brain Death Consensus
Despite the release of the Evidence-based guideline update, which sought to unify the BD
determination across all institutions, protocol for diagnosis differs significantly across the United
States. In the 2016 investigation Variability of Brain Death Policies in the United States, which
surveyed 492 hospitals across the 50 states, it was found that not all had adopted the guidelines
as proposed by the AAN. The AAN states that no neurological expertise is required for BD
diagnosis, however the physician should be well versed in the respective criteria. Despite this,
33.1% of the sampled institutions required neurological expertise for BD determination (Greer,
et al., 2016, p. 214). In addition, 43.1% also specifically require an attending physician for the
examination, regardless if that physician is versed in neurology. Interestingly, there are eight
institutions that allow more junior physicians, or other medical professionals, to conduct the
clinical examination. The AAN also states that only one clinical examination is needed for BD
determination. However, the majority (65.9%) require two separate examinations and only
13.0% mandate one examination. Hospitals that require two examinations generally mandate that
they must be conducted by different physicians. There are also varying lengths of waiting
periods required when multiple examinations are needed. Most hospitals require at least six
hours (71.1%), while the vast minority stipulate 24 hours (1.1%). Waiting periods, generally for
24 hours, are also mandated in the event of cardiac arrest, though only in 7.1% of hospitals
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(Greer, et al., 2016, p. 215). Long waiting periods, in general, are suggested to negatively impact
organ donation (Greer, et al., 2016, p. 217). The prerequisites for the clinical examination also
differ significantly. The majority follow the AAN guidelines, with 82.9% require establishing the
cause of coma, and 73.9% require the complete absence of all medications including sedatives
and paralytics. The majority (73.9%) also require the absence of any possible confounding
conditions, yet of these policies, only 71.1% mandate the additional absence of endocrine
disorders (Greer, et al., 2016, p. 215). It is alarming that a significant percentage do not follow
the AAN prerequisites, indicating a higher likelihood for error for such institutions. Pertaining to
the clinical examination, nearly all (97.4%) policies require apnea testing, yet the functional
analysis of the brain stem differs significantly. For example, though nearly all (92.9%) require
the lack of pupillary responses, only 28.7% examine constriction of the pupils. In addition, a
significant minority (22.6%) examine the “jaw jerk reflex” (Greer, et al., 2016, p. 215).
Following clinical examination, 6.5% of the institutions require ancillary testing. For all
institutions, when ancillary testing is used, the majority (78.8%) utilize the EEG. Evoked
potentials are also still mandated in 26.1%, CTA in 9.0%, and MRA in 2.9%, all of which are not
endorsed by the AAN (Greer, et al., 2016, p. 216-217). The minority of hospitals that do not
follow the AAN recommendations, especially for expertise in BD criterion, fulfillment of
prerequisites, thorough analysis of brain stem function, and utilization of invalidated ancillary
tests, are of a significant concern.
Though the AAN describes neurologists as having utmost expertise in determining a BD
diagnosis, consensus amongst such professionals also varies widely. Interestingly, in a survey of
192 neurologists in the United States, when asked to give a conceptual justification for equating
BD as death, 50% of respondents referred to the loss of higher brain function itself, while only
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29% actually justified it as the irreversible loss of integration of bodily functions by the brain”
(Joffe, et al., 2012, p. 4). Referring to BD as equivalent to death due to the loss of higher brain
function reflects a significant conflict with the AAN standard. It should also be noted that the
vegetative state could also be justified with such a response. Perhaps more startling, when
explicitly asked if BD was the same as cardiac death, the majority (54%) responded “no” (Joffe,
et al., 2012, p. 4). This survey demonstrates that even neurologists themselves, despite being
considered experts in BD, express uncertainty about the criteria, and cannot provide ample
justification in equating it to death.
This lack of uniformity is not limited to the United States. There is a notable lack of BD
consensus globally, varying in both sociocultural perceptions, as well as diagnosis protocol. In a
worldwide survey of 94 countries, 57% of respondents do not equate BD with cardiac death
(Wahlster, et al., 2015, p. 1872). The use of mandated ancillary testing is also relatively frequent
(29% of all countries surveyed). Interestingly, in conflict with the AAN, the majority (56%)
consider activity derived from ancillary testing to be incompatible with a positive clinical
examination, refuting a claim of BD (Wahlster, et al., 2015, p. 1875).
False-Positive Diagnoses and Residual Function
Despite movements to increase uniformity in BD diagnosis by the AAN, false-positive
claims, as well as depictions of reversibility, are still current. In contrast, the AAN states that
there are currently no documented cases of BD false-positives and reversibility, with any cases
suggesting such claims determined to be confounded (Wijdicks, et al., 2010, p. 1911). One such
case, though confounded by the AAN, had presented “reversible BD” as a possibility when faced
with induced hypothermia and cardiopulmonary arrest (Webb & Samuels, 2011). The case report
details a 55-year-old man experiencing respiratory failure who was placed into an intensive care
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unit following cardiopulmonary resuscitation. Within the first hour, the patient became
comatose, with noncontrast head tomography scans revealing swelling, effacement, and
indistinct white and gray matter junctions (Webb & Samuels, 2011, p. 1538). To prevent brain
herniation, at hour 16, the patient was subjected to induced hypothermia. However, at hour 56,
the patient had lost nearly all brain stem function and had minimal EEG activity. At hours 72 and
78, two clinical examinations following the AAN guideline were administered by separate
neurologists. Both clinical examinations and the following apnea test were consistent with BD
criterion, allowing pronouncement of death. However, at hour 98 the patient had regained the
cough reflex, corneal reflex, and spontaneous respiration (Webb & Samuels, 2011, p. 1539). The
BD diagnosis and determination of death were revoked. Nonetheless, the patient suffered from a
profound brain trauma that resulted in the subsequent absence of cerebral blood flow, resulting in
death (Webb & Samuels, 2011, p. 1540). The case report mentioned urges caution in diagnosing
following hypothermia and cardiopulmonary arrest. This warning is significant as Webb and
Samuels had also mentioned that nearly 25% of all organ donors constitute individuals diagnosed
as brain dead following cardiac arrest (Webb & Samuels, 2011, p. 1541). However, despite their
claims, it is highly unlikely that this case depicts an actual “reversible BD” scenario. Rather, it is
far more likely to reflect a false-positive diagnosis, but, regardless, casts significant doubt on
whether the recommended AAN criterion is sufficient enough to diagnose BD in all scenarios.
False-positive claims are also depicted in “BD mimic” cases. Currently, the AAN
describes several “mimic” cases that fulfill the criteria for BD. The cases depict conditions such
as “Guillain-Barré syndrome (GBS), organophosphate intoxication, high cervical spinal cord
injury, lidocaine toxicity, baclofen overdose, and delayed vecuronium clearance” that could
present challenges in establishing a BD diagnosis. However, such cases were determined to be
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relatively insignificant, as such studies suggesting mimicry had not completely followed the
AAN guideline (Wijdicks, et al., 2010, p. 1912). However, such cases were determined to be
insignificant as they had not followed the guideline recommended by the AAN. Nonetheless, six
years after the release of the Evidence Based Guideline Update, another BD mimic case of GBS
was reported. GBS is described as set of chronic, autoimmune disorders resulting in degeneration
of the peripheral nervous system, particularly nerves innervated with muscles (Niemi, 2013).
Interestingly, it is also the only disorder currently stated by the AAN to fulfill BD criteria. In a
2016 case report, a 60-year-old man suffering from acute motor axonal neuropathy, a form of
GBS, fulfilled the clinical criteria for BD, including lack of brainstem function and a positive
apnea test. However, the patient had not suffered from any form of severe brain trauma,
provoking uncertainty despite a positive clinical assessment implicating BD. The physicians
conducted an EEG analysis, and discovered significant cortical activity, disproving the results of
the clinical BD assessment (Ravikumar, et al., 2016). The patient had survived the GBS incident,
recovering consciousness and significant function over time (Ravikumar, et al., 2016).
Unnervingly, had the physicians strictly followed the guidelines set by the AAN, the patient
would have been misdiagnosed as brain dead.
Although BD is supposed to reflect the total loss of integrative bodily function by the
brain, residual functions remain even after diagnosis. Even those diagnosed with BD can exhibit
neuroendocrine homeostasis, maturation, immune responses, support gestation of a fetus, and
respond to bodily harm (Nair-Collins, 2017, p. 526). The sheer number of residual functions is
problematic, and casts significant doubt onto what is considered a critical function for
maintaining integrity of the organism. It is then likely that the criterion established by the AAN
are not sufficient, and may not be applicable in every BD scenario.
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Public Perception and Rights
The concept of BD is poorly understood by the general population. The media tends to
sensationalize BD scenarios, and internet sources that laymen tend to gravitate to are not
credible, both of which do not aid in the public’s education of the matter. Misinformation
regarding the state of BD only create further animosity towards the medical community
regarding end of life decisions. In an investigation of internet sources like Google and YouTube,
nearly 40% of top websites described BD inaccurately while also referencing organ donation
90% of the time (Jones, et al., 2018, p. 3). Pertaining to YouTube, the majority 60% also
promoted inaccurate BD statements, and often used the terms “vegetative state” and “coma”
interchangeably (Jones, et al., 2018, p. 4). In such videos, negative tones were the most
prevalent, with only hostility expressed towards organ donation and physicians (Jones, et al.,
2018, p. 5). It is clear that the general public, perhaps as a result of being misinformed, are wary
and distrustful of the medical community regarding BD.
Pertaining to organ donation, it is a common misconception amongst the general
population that establishment of the BD diagnosis was put in place to benefit live organ
donation. As stated earlier, successful organ transplantation and the establishment of BD was
occurring in parallel. Nonetheless, despite their independent realizations, organ donation and BD
cannot realistically be viewed as separate entities, neither in legislature, net or in the public view
(Machado, et al., 2007). Even members of the Ad Hoc Committee, the first to formally establish
BD criterion, believed that organ donation from such patients could be beneficial (Verheijde, et
al., 2009). Today, the majority of organ donation arises from procurement from BD patients
(Nair-Collins, 2017, p. 526). Organ removal itself is deemed impermissible if it results in the
death of the individual, as stated by the Dead Donor Rule (DDR). However, given that the
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establishment of the UDDA allowed accordance with the DDR, organ removal from BD patients
is deemed permissible (Nair-Collins, 2017, p. 526). However, not all agree with this legality,
believing organ donation to be a violation of moral status. The residual, homeostasis maintaining
functions could suggest the organism to at least be “biologically” alive (Nair-Collins, 2017). If
that is the case, removing organs without explicit consent would infringe upon moral status,
destroy the biological integrity of the organism, causing death, and would violate the DDR.
Regarding rights, it is important to consider the representatives, often familial, of BD
patients, whom ultimately determine the end of life decisions. In some states, consideration for
such representatives is becoming lost in favor of establishing more uniform BD policies. In 2017,
the Nevada Supreme Court had determined that informed consent is not required to make a BD
diagnosis--particularly in conducting the apnea test (Assembly Bill, 2017). In this manner, BD
diagnosis by the AAN becomes equivalent to “irreversible cessation of circulatory and
respiratory function” which does not require consent to establish death of the patient (Assembly
Bill, 2017). This undermining of the BD patient’s representatives may only heighten the existing
distrust from the general population. It should be noted that death is not limited to biological
viewpoints, and encompasses a variety of religious perspectives. Not all religions accept BD, and
believe the absence of circulation to establish death (Robert & Robert, 2017). The apnea test, and
corresponding brain stem functional analysis, may also be considered invasive. Even when there
is a declaration of death, invasive procedures still require consent of familial representatives
(Mohamed, et al., 2017). However, there is a minority of states that do accommodate for
opposing views of BD. California, Illinois, New Jersey, and New York are the only states that
allow families to refute BD as death on religious grounds (Nelson, 2017, p. 499).
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Discussion
Although BD was originally formulated to resolve the dilemma of the irreversible,
comatose patient, its creation has resulted in an increasing number of ethical, legal, and medical
conflicts. The varying, and numerous controversies suggest that there is still much uncertainty
whether the irreversible loss of the critical functions of the brain, including the brainstem, can be
accurately determined by the AAN guidelines. BD is also still a relatively new term, having only
been formally established in 1968, and enacted nationally for around 37 years since the
introduction of the UDDA. Though the field of neuroscience and ancillary tests continue to
evolve, implementation into BD criterion has been stagnate. Given that the AAN criterion only
rely on practical, indirect assessments of brain function, further research in ancillary testing is
critically needed to clarify any discrepancies. Widespread brain trauma outside of the brain stem
can only be assessed via ancillary testing like the EEG. Given this, ancillary examinations using
validated measures could serve as a preventative measure, and should be reconsidered as a
critical component to the clinical examination. Nonetheless, at the least, uniformity in the preclinical examination, and a more standardized, minimal observation period are needed. Though
the majority of institutions follow the AAN prerequisites, it is alarming that a significant portion
do not make efforts to eliminate any, and all, confounding factors. A standardized observation
period should also be considered to eliminate any chance of recovery, and give sufficient time
for familial representatives to establish end of life decisions. Though longer waiting periods may
negatively impact organ donation, it is important to note that harvesting of such would be
unethical if the patient had any hope of recovery. Up until the patient is officially documented as
dead, the individual still retains moral status, and is deserving of equal treatment that any other
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patient could be afforded. Physicians must be wary of their own disposition, as utilitarian
motives may only build distrust in the families of BD patients.
Uneasiness of the general population regarding BD is valid when considering that there is
still no professional consensus, and that acceptance of such may require reworking of
sociocultural norms. It may be unreasonable to expect laymen to simply equate BD to the
traditional model of death given the current state. Nonetheless, it is the duty of the medical
community to reaffirm confidence within the general population. Thus, physicians must strive to
eliminate any margin of error, as any false-positive diagnoses will result in irreversible, fatal
consequences. In doing so, trust of the general population will be restored in the medical
community regarding end of life decisions.

Limitations
The controversies of BD are incredibly wide, and this review barely encompasses the
sheer breadth of corresponding topics. The overview of literature only presents controversies of
BD determination for adults. BD diagnosis in children differs, and has been omitted from this
study. This study simply seeks to present a sample of BD topics in philosophical, legal, and
medical realms.
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